• HOME

  • GOOD NEWS

  • DISCOVERIES

  • INNOVATIONS

  • GLOBAL GOOD

  • GREEN IMPACT

  • CELEBRITIES

  • GNI

  • PODCAST

  • More

    Use tab to navigate through the menu items.

    The Brighter Side of News features good news, compassionate news  and inspirational news from around the world

    • 131_Flipboard_logo_logos-512
    • LinkedIn
    • Facebook
    • Instagram
    • RSS
    BSN header logo 1.fw.png
      Sign up for the Brighter Side of News newsletter
    Harvard researchers discover the cause of multiple sclerosis
    Joseph Shavit
    • Jun 9

    Harvard researchers discover the cause of multiple sclerosis

    Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.
    Harvard scientists discover the cause of multiple sclerosis
    Joseph Shavit
    • May 9

    Harvard scientists discover the cause of multiple sclerosis

    Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.
    Harvard researchers discover the cause of multiple sclerosis
    Joseph Shavit
    • Apr 9

    Harvard researchers discover the cause of multiple sclerosis

    Multiple sclerosis (MS), a progressive disease that affects 2.8 million people worldwide and for which there is no definitive cure.
    Ketogenic diet significantly improves patients with Multiple Sclerosis
    Joseph Shavit
    • Mar 12

    Ketogenic diet significantly improves patients with Multiple Sclerosis

    Patients with multiple sclerosis (MS) who adopted a high-fat, low-carbohydrate ketogenic diet saw significant improvements in their MS.
    Engineer develops imitation red blood cells to deliver lifesaving drugs
    Joseph Shavit
    • Mar 2

    Engineer develops imitation red blood cells to deliver lifesaving drugs

    U of A researcher is building new drug delivery vehicles could improve efficacy and reduce negative side effects of lifesaving drugs.
    It's not a COVID cure but study finds hydroxychloroquine may treat multiple sclerosis
    Joseph Shavit
    • Jan 17

    It's not a COVID cure but study finds hydroxychloroquine may treat multiple sclerosis

    Hydroxychloroquine, also known by the brand name Plaquenil, is a prescription drug that is used in the treatment of malaria and arthritis.
    Harvard researchers discover the leading cause of multiple sclerosis
    Joseph Shavit
    • Jan 14

    Harvard researchers discover the leading cause of multiple sclerosis

    It suggests that most MS cases could be prevented by stopping EBV infection, and that targeting EBV could lead to the discovery of a cure.

    © 2021 The Brighter Side of News

    Site Map | Newsletter Sign-up | News Feed | About Us | Privacy | Terms

    • LinkedIn
    • Facebook
    • Instagram